Moderna, Inc. is a biotechnology company focused on messenger RNA (mRNA) medicines and vaccines. Its portfolio centers on products for respiratory and infectious diseases, including COVID-19 and RSV vaccines, alongside a pipeline that extends into oncology, rare diseases, autoimmune disorders, and other therapeutic areas. The company uses its mRNA platform to design medicines that instruct cells to produce proteins with preventive or therapeutic potential, making it an important developer in modern biopharmaceutical research. Moderna, Inc. also maintains integrated manufacturing capabilities and commercial operations that support the development, production, and distribution of its current products and clinical programs. Headquartered in Cambridge, Massachusetts, and founded in 2010, Moderna, Inc. plays a notable role in advancing mRNA-based treatments and vaccines across global healthcare markets.